Carbazochrome Sodium Sulfonate CAS NO.：51460-26-5

Carbazochrome sodium sulfonate Basic information

Carbazochrome sodium sulfonate Physical and Chemical Properties

Carbazochrome sodium sulfonate Usage

Sodium carlosalin is a new generation hemostatic agent, a derivative of carlosalin sodium (Anluoxue), which introduces sodium sulfonate group in the molecular structure, which overcomes the low solubility of carlosalin sodium and the dependence on salicylic acid The disadvantages of acid solubilization, so that the hemostatic effect is more obvious. In addition, it does not contain salicylic acid groups, so it does not produce hemolysis, does not affect hematopoietic function, and has low irritation. It is safe to use; it has no adrenal gland effect, and does not cause blood pressure and heart rate fluctuations; it does not affect the blood coagulation mechanism and has a rapid onset. The effect is lasting. It has been widely used in foreign countries to treat capillary fragility in hypertension, to prevent the onset of stroke, and to stop bleeding in many aspects such as pulmonary hemorrhage, gastrointestinal hemorrhage and postpartum hemorrhage. At present, the drug is mainly used in China for a variety of bleeding caused by increased capillary permeability, such as bleeding in the urinary system, upper digestive tract, respiratory tract, and obstetrics and gynecology. It has a significant effect on urinary system bleeding, and can also be used for the prevention and treatment of trauma and surgical bleeding, so it has been more and more widely used in clinical practice.